Introduction
High levels of glycosylated hemoglobin (HbAj) are observed in patients suffering from poorly controlled diabetes mellitus [19] . Measurement of glycosylated hemoglobin has proved to be a valuable clinical tool of long-term diabetes control since it represents an objective and reliable indicator of overall blood glucose concentrations during the previous eight weeks [3, 18] . HbAj comprises three main fractions la, Ib and Ic. HbA lc is formed through non-enzymatic condensation of a molecule of the aldose sugar glucose with the amino terminal valine of the hemoglobin jß-chain, and it is actually the amount of HbA lc in its stable ketoamine form which reflects the integrated glycemia of the previous two months and makes possible the use of HbAjL measurement as a means of glucose regulation assessment [9] . HbA la contains hemoglobin adducts of glucose-6-phosphate and fructose-1,6-diphosphate [13] , and HbA lb is probably a deamidation product of hemoglobin [10] . The HbAj elevation in diabetic blood samples is only related to the HbA lc component, whereas the concentrations of HbA la and HbA lb do not differ in non-diabetic and diabetic subjects, as CASTAGNOLA et al. [2] demonstrated recently by macrochromatographic fractionation of HbA l from non-diabetic and diabetic subjects. The latter evidence implies that HbA! assay -without separated measurement of the HbA lc component -is a clinically satisfactory method of glucose regulation monitoring. HbA lc , as a stable ketoamine is derived by rearrangement from a labile reversible Schiff base adduct [6] whose content depends on short-term blood glucose variations. Once the ketoamine has formed, the condensation product of human adult hemoglobin and glucose remains irreversible during the life span of the red cells [1, 4] . Thus, blood glucose leaves its specific chemical engramme on the hemoglobin molecule. Non-enzymatic glycosylation does occur also in long half-life proteins other than hemoglobin and can theoretically lead to alterations of their structural and functional properties. These alterations could play a role in the genesis of diabetic complications such as nephropathy, vasculopathy or cataracts. The main objectives of the present study are to clarify a) what values of glycosylated hemoglobin are to be encountered in untreated gestational diabetes during late pregnancy and how these values do differ from those in non-diabetic mothers, and b) whether and to what extent measurements of glycosylated hemoglobin are suitable for the diagnosis or diagnostic exclusion of gestational diabetes. In addition, the neonatal outcome from the gestational diabetics -after appropriate treatment of their metabolic disturbance -is compared with that from the non-diabetic mothers. * Body weight prior to last pregnancy was presented according to the personal statements of the women. -Data presented: χ ± s.d.
Patients, materials and methods

Subject groups
Determinations of glycosylated hemoglobin were done in 153 women: Group I: 69 non-diabetic mothers who were delivered of normal weight infants at term. Group II: 33 non-diabetic mothers who were delivered of macrosomic infants at term. Group HI: 51 gestational diabetics in the 3rd trimester before the onset of the diabetes therapy. Table I shows some anthropological data on the women examined. It should be noted that the gestational diabetics (Group III) were on the average 4 to 5 years older and 8 to 9 kg heavier than the non-diabetic women. In this group, one out of five suffered from obesity, i.e. an overweight of at least 20% above normal. In contrast, in the non-diabetics examined (Group I and II), only 4% were obese prior to and during pregnancy. Normal birthweight of the infants was defined as being between the 10th and 90th percentiles for gestational age according to the birthweight curves of NiCKL [15] which describe the relative frequency of birthweight by week of gestation for the German population. The macrosomic infants had a birthweight above the 90th percentile and almost all of them weighed more than 4000 g.
Oral glucose tolerance test
The assessment of glucose regulation was done during the 3rd trimester by means of the oral glucose tolerance test (OGTT, 100g). The tests commenced at 8 o'clock in the morning after overnight fasting. The glucose concentration was measured in the plasma of capillary blood using a glucose oxidase method in a Glucose Analyzer II, Beckman. To differentiate the non-diabetic cases from the gestational diabetic cases, the blood glucose criteria of Q'SULLIVAN and MAHAN [17] were applied; they were modified for the enzymatic glucose assay in capillary plasma. A patient was diagnosed as diabetic if at least two glucose values exceeded the following limits: 0 hours IpOmg/lOOml, 1 hour 190mg/100ml, 2 hours 170mg/100 ml. Figure 1 gives an overall representation of the plasma glucose levels measured during oral glucose tolerance test in our 3 subject groups. 
Samples
For glycosylatcd hemoglobin assay, venous blood anticoagulated with EDTA was used. Blood was withdrawn early in the morning after overnight fasting. In Groups I and II sample collection was done on the first or second day after delivery, in Group III at the latest 4 weeks prior to delivery and before onset of the diabetes therapy. If not freshly processed, the samples were stored in a refrigerator at 2 to 4°C. All samples were processed within 48 hours after withdrawal.
Assay of glycosylated hemoglobin (HbA i)
Glycosylatcd hemoglobin was determined by cation-exchange chromatography in small disposable columns, 0.9 χ 10 cms. (BOEHR1NGER, Mannheim). We chromatographed the hcmolysates of unwashed erythrocytes on the ion-exchange resin (Biorex 70 or Amberlite IRC 50, l g per column) equilibrated with phosphate buffer, 40 mmol/L, pH6.7. After elution with the phosphate buffer of the "fast" Chromatographie fraction (HbA!), we compared the absorbance at 415 nm of the fast fraction with the absorbance of the second fraction -containing the "other", i.e. non-glycosylated hemoglobin, which was eluted by a sodium chloride solution, 400 mmol/L. Applying a simple mathematical equation, from the absorbances of the two Chromatographie fractions the percentage of glycosylated hemoglobin in relation to total hemoglobin could be easily calculated. All chromatographies were made at a regulated room temperature of 23 °C. Samples and solutions used were equilibrated at this temperature prior to chromatography. In addition the column temperature was stabilized with a temperature-controlled water jacket at 23 °C. To ensure the validity of the results, in each Chromatographie set of unknown samples a commercial control hemolysate with known content of glycosylated hemoglobin ("HbA, Control normal", BOEHRINGER, Mannheim) was run. The intra-assay coefficient of variation for the method was 1.9% (n = 6), the inter-assay coefficient of variation amounted to 4.7% (n = 17) in the range of 6.8% and 7.5% of HbAj.
3 Results and comments 3.1 Glycosylated hemoglobin in the 3 subject groups Table II shows the accumulated values of glycosylated hemoglobin to be encountered in the 3 subject groups. The mean HbAj values from the non-diabetic mothers with normal weight neonates (Group I) and from the non-diabetic mothers with macrosomic neonates (Group II) are very similar to each other and amount to 6.51% and 6.59% respectively. There is no statistically significant correlation between the HbAj values and the neonatal birth weights. Gestational diabetics prior to specific therapy (Group III) demonstrate a mean HbA! value of 7.11%. The HbA! values from the gestational diabetics differ significantly from those obtained in the two non-diabetic subject groups: Group I vs. Group Group I) or below 6.0% (x -2 s. d. for Group III) will prove or exclude with a high degree of probability the existence of gestational diabetes. This is valid if there are no severe concomitant diseases in the pregnant woman which could alter the rate of HbAj (for instance hemolytic anemia, renal insufficiency, pre-gestational overt diabetes mellitus) and she did not receive a prolonged therapy with agents known to cause hyperglycemia (sympathicomimetic agents, thiazide diuretics, corticosteroids etc.) before HbAj assay. Table III presents clinical data on the neonates from the mothers examined. The macrosomic neonates from non-diabetic mothers had an average overweight of almost 1 kg compared with that of their normal weight counterparts. The rate of delivery by cesarean section in the macrosomic group II was twice as high as that in Group I. As judged by the SALING score [20] recorded 5 minutes after delivery, the postpartum status of the macrosomic infants was just as good as that of the normal weight infants of Group I. Their mean plasma glucose concentration measured one hour after delivery was slightly lower than that in the infants of Group I. In the neonates of our gestational diabeticsappropriately treated -the average birthweight amounted to 3405 g and was 150 g higher than that in Group I. Their mean plasma glucose concentration recorded one hour after delivery was the same as that in the macrosomic infants of Group II, i.e. 49 mg/100 ml. In 10 of the infants investigated however, hypoglycemias with plasma glucose levels below 40 mg/100 ml were observed. The postpartum status of the neonates from the gestational diabetic women was nearly as good as that of the infants from the non-diabetic mothers.
Neonatal outcome in the 3 subject groups
-In this connection it must be emphasized that the gestational diabetics received a closely controlled therapy with appropriate diet, and in some cases with additional insulin injections. Taken as a whole, the infants of the gestational diabetics did not suffer serious impairment caused by the maternal metabolic disorder, provided it was treated in time and consistently. The scoring criteria of SALING [20] for the assessment of the postpartum status are similar to those of APGAR. "Placental weight'' includes the weight of the membranes and of the placenta-adherent proportion of the cord. -Data presented: χ ± s.d.
The ratios between placental weight: neonatal weight in the non-diabetic groups and the gestational diabetic group were virtually identical: Group I 0,19, Group II 0,18, Group III 0,19.
Discussion
In the present study the quantity of glycosylated hemoglobin in non-diabetic mothers with normal OGTT during late pregnancy and normal weight offspring, (Group I) was 6.51 ±0.46% of total hemoglobin. GAIN et al. [5] using an ion-exchange Chromatographie assay very similar to ours, demonstrated that HbAx in non-pregnant persons with normal OGTT amounted to 6.45 ±0.62%. Obviously, there is no appreciable difference between the HbA l levels in pregnant and non-pregnant subjects with normal glucose regulation. (Fig. 3) . Under these circumstances, in the majority of cases with suspected gestational diabetes, HbA t assay cannot simply replace the classical oral glucose tolerance test to make the diagnosis. As a rule, the two tests must be complementarily applied for diagnostic ascertainment or exclusion of gestational diabetes.
Since the individual level of glycosylated hemoglobin is a rather inert and slowly changing parameter, HbAj values measured in maternal blood samples withdrawn a few days after delivery are can be important for,the mother with regard to the proper management in case of a future pregnancy, which would in all probability be complicated by gestational diabetes again. For the time being, HbAj assay by means of miniaturized cation-exchange chromatography columns, based on the work of TRIVELLI et al. [23] , is the method of choice in clinical use [11, 14, 16] . Since measurements of HbA l can now be carried out accurately, precisely and promptly, they are a useful tool in diagnosing and monitoring diabetes mellitus of all types. Recently HbA t assays have also been applied for detection of impaired glucose tolerance in non-pregnant patients [5, 7, 24] . The present paper attempts to show the possibilities and limitations in diagnosing gestational diabetes by quantitation of glycosylated hemoglobin. In order to draw the proper medical conclusions from the HbAj values obtained from the intermingling zones of normal glucose regulation in pregnancy and gestational diabetes, a high degree of reliability of the measurements is demanded. To avoid erroneously high HbA! readings caused by the labile aldimine fraction [8] , blood samples should be obtained after overnight fasting. They should be stored for no longer than 3 days at 23°, 2 to 4° or -20°C, until their processing [21, 22] , because the ion-exchange methods are associated with a marked increase in HbA! values after prolonged sample storage [12] . Another important source of incorrect HbA! results is chromatography at different temperatures. On observance of some intrinsic premisses, HbA l assay can be used as a suitable additional chemical indicator in the diagnostic confirmation or exclusion of gestational diabetes.
Summary
Glycosylated hemoglobin (HbAx) was determined in three subject groups: 69 non-diabetic mothers who were delivered of normal weight infants at term (Group I), 33 non-diabetic mothers who were delivered of macrospmic infants (>4000g) at term (Group II), 51 gestational diabetics in the 3rd trimester -before onset of the diabetes therapy (Group III). In all three groups diagnostic assessment of glucose regulation was done by means of the oral glucose tolerance test during the 3rd trimester. Glycosylated hemoglobin was assayed by cation-exchange chromatography in small disposable columns.
The mean values and standard deviations of HbA! were 6.51 ± 0.46% in Group I, 6.59 ± 0.42'% in Group II and 7.11 ± 0.56% in Group HI. Between the HbA t values of Group III (gestational diabetes) on the one hand and those of the non-diabetic groups I and II on the other, there were highly significant differences (p < 0.001; x 2 -test). HbAj values above 7.4 % -i.e. above + 2 s. d. of HbA! in the non-diabetic mothers -were with 95 % probability abnormal and indicative of gestational diabetes. HbAj values between 7.0% and 7.4% were suspected of impaired glucose tolerance and gestational diabetes respectively.
Between the HbAj levels in the non-diabetic groups and those in the gestational diabetic group there was a vast zone with overlapping values. HbAj data situated in this transitional area could be found both in non-diabetic subjects and also in those with abnormal glucose regulation. HbAj values below 6.0% excluded gestational diabetes or otherwise impaired glucose tolerance with a high degree of probability.
As to the neonatal outcome, there were no remarkable differences in the postpartum status of the three groups investigated. The macrosomic infants of Group II were on the average 1 kg heavier than the normal weight infants of Group I. Their rate of cesarean section was twice as high as that in Group I. In the gestational diabetic group the average neonatal birthweight was 150 g higher than that of the normal weight infants of non-diabetic mothers. The infants of the gestational diabetic women showed an increased tendency to develop moderate postpartual hypoglycemias. It is noteworthy that the non-selected gestational diabetic women in our study were on the average 8 to 9 kgs havier and 4 to 5 years older than their non-diabetic counterparts. They received a closely controlled diabetes therapy during the 3rd trimester of pregnancy. aire de transition peuvent jetre trouvees ä la fois chez des patientes non diabetiques et ä la fois chez des patientes presentant une anomalie de la regulation glucidique. Les valeurs d'HbAx infenieures ä 6 % elimment un diabete gestationel et egalement une tolerance glucidique anormale avec une probabilite tres elevee. II n'y a pas de differences remarquables dans 1'etat au cours du post-partum comme dans le devenir neo-natal dans les trois groupes explores. Les enfants macrosomes du groupe II pesent en moyenne un Ig de plus que les enfants de poids normal du groupe I. Le pourcentage de cesärienne est deux fois plus eleve que dans le groupe I. Dans le groupe des diabetiques la moyenne des poids de naissance est plus elevee de 150 g que celle des enfants de meres non diabetiques. Les enfants des meres ay ant presente un diabete gestationel montrent une tendance accrue ä presenter une hypoglycemie moderee du postpartum. II est remarquable que dans notre etude les patientes non selectionnees avec un diabete gestationel pesent en moyenne 8 ä 9 Kg de plus et sont de 4 a 5 ans plus ägees que les temoins non diabetiques. Elles on t requ un traitement etroitement surveille au cours du 3eme trimestre de la grossesse.
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